Jessica Pollard, who has been teaching at the Yale University School of Medicine, returns to her native state to lead an office that plays a key role in responding to the opioid crisis.
opioid epidemic
States split by party on accepting Purdue Pharma settlement
Republican state attorneys general chiefly support a tentative multibillion-dollar settlement with the OxyContin maker, while their Democratic counterparts mostly oppose it.
Opioid talks at impasse; Purdue bankruptcy filing expected
Attempts to reach a nationwide settlement over the opioid crisis with OxyContin maker Purdue Pharma have stalled.
Commentary: Usual responses to drug epidemics won’t reverse fentanyl fatalities
Solutions should focus on creative supply disruption, supervised opioid use sites and new forms of treatment.
Trump administration announces nearly $2 billion in opioid grants
The money is destined for states and local governments to help provide treatment and recovery services.
The Maine Millennial: Accounting for pain got lost amid addiction to profit
Drug companies and liquor bottlers can’t be expected to regulate themselves.
U.S. Attorney Frank: Law enforcement had key role in decline in Maine overdose deaths
Though recent coverage didn’t mention it, a surge in federal prosecutions has been a deterrent to users and dealers.
Maine gets $6 million in federal funding to address opioid crisis
Community health centers, hospital networks and the University of Maine are recipients of money to support treatment programs and workforce development in the treatment sector.
As use of opioid antidote increases, drug overdose deaths decline
Naloxone doses are now widely available in Maine pharmacies, although a new federal database shows significant variations in sales by county.
Emergency hospital admissions for drug overdoses have declined in Maine since 2017
The trend mirrors a statewide decrease in overdose deaths, with improved access to Suboxone and naloxone.